These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 37600947)
1. Mode of action studies confirm on-target engagement of lysyl-tRNA synthetase inhibitor and lead to new selection marker for Hanna JC; Corpas-Lopez V; Seizova S; Colon BL; Bacchetti R; Hall GMJ; Sands EM; Robinson L; Baragaña B; Wyllie S; Pawlowic MC Front Cell Infect Microbiol; 2023; 13():1236814. PubMed ID: 37600947 [TBL] [Abstract][Full Text] [Related]
2. Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis. Baragaña B; Forte B; Choi R; Nakazawa Hewitt S; Bueren-Calabuig JA; Pisco JP; Peet C; Dranow DM; Robinson DA; Jansen C; Norcross NR; Vinayak S; Anderson M; Brooks CF; Cooper CA; Damerow S; Delves M; Dowers K; Duffy J; Edwards TE; Hallyburton I; Horst BG; Hulverson MA; Ferguson L; Jiménez-Díaz MB; Jumani RS; Lorimer DD; Love MS; Maher S; Matthews H; McNamara CW; Miller P; O'Neill S; Ojo KK; Osuna-Cabello M; Pinto E; Post J; Riley J; Rottmann M; Sanz LM; Scullion P; Sharma A; Shepherd SM; Shishikura Y; Simeons FRC; Stebbins EE; Stojanovski L; Straschil U; Tamaki FK; Tamjar J; Torrie LS; Vantaux A; Witkowski B; Wittlin S; Yogavel M; Zuccotto F; Angulo-Barturen I; Sinden R; Baum J; Gamo FJ; Mäser P; Kyle DE; Winzeler EA; Myler PJ; Wyatt PG; Floyd D; Matthews D; Sharma A; Striepen B; Huston CD; Gray DW; Fairlamb AH; Pisliakov AV; Walpole C; Read KD; Van Voorhis WC; Gilbert IH Proc Natl Acad Sci U S A; 2019 Apr; 116(14):7015-7020. PubMed ID: 30894487 [TBL] [Abstract][Full Text] [Related]
4. Spontaneous Selection of Hasan MM; Stebbins EE; Choy RKM; Gillespie JR; de Hostos EL; Miller P; Mushtaq A; Ranade RM; Teixeira JE; Verlinde CLMJ; Sateriale A; Zhang Z; Osbourn DM; Griggs DW; Fan E; Buckner FS; Huston CD Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33753338 [TBL] [Abstract][Full Text] [Related]
5. Genetic crosses within and between species of Shaw S; Cohn IS; Baptista RP; Xia G; Melillo B; Agyabeng-Dadzie F; Kissinger JC; Striepen B Proc Natl Acad Sci U S A; 2024 Jan; 121(1):e2313210120. PubMed ID: 38147547 [TBL] [Abstract][Full Text] [Related]
6. Toolkit of Approaches To Support Target-Focused Drug Discovery for Milne R; Wiedemar N; Corpas-Lopez V; Moynihan E; Wall RJ; Dawson A; Robinson DA; Shepherd SM; Smith RJ; Hallyburton I; Post JM; Dowers K; Torrie LS; Gilbert IH; Baragaña B; Patterson S; Wyllie S ACS Infect Dis; 2022 Sep; 8(9):1962-1974. PubMed ID: 36037410 [TBL] [Abstract][Full Text] [Related]
7. A Conditional Protein Degradation System To Study Essential Gene Function in Cryptosporidium parvum. Choudhary HH; Nava MG; Gartlan BE; Rose S; Vinayak S mBio; 2020 Aug; 11(4):. PubMed ID: 32843543 [No Abstract] [Full Text] [Related]
12. Recent advances in genetic manipulation of Cryptosporidium. Vinayak S Curr Opin Microbiol; 2020 Dec; 58():146-152. PubMed ID: 33161368 [TBL] [Abstract][Full Text] [Related]
13. Phenotypic screening techniques for Love MS; McNamara CW Expert Opin Drug Discov; 2021 Jan; 16(1):59-74. PubMed ID: 32892652 [No Abstract] [Full Text] [Related]
14. A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis. Love MS; Beasley FC; Jumani RS; Wright TM; Chatterjee AK; Huston CD; Schultz PG; McNamara CW PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005373. PubMed ID: 28158186 [TBL] [Abstract][Full Text] [Related]
15. Oocyst Shedding Dynamics in Children with Cryptosporidiosis: a Prospective Clinical Case Series in Ethiopia. Johansen ØH; Abdissa A; Bjørang O; Zangenberg M; Sharew B; Alemu Y; Moyo S; Mekonnen Z; Langeland N; Robertson LJ; Hanevik K Microbiol Spectr; 2022 Aug; 10(4):e0274121. PubMed ID: 35699433 [TBL] [Abstract][Full Text] [Related]
16. In silico identification and validation of a novel hypothetical protein in Cryptosporidium hominis and virtual screening of inhibitors as therapeutics. Shrivastava AK; Kumar S; Sahu PS; Mahapatra RK Parasitol Res; 2017 May; 116(5):1533-1544. PubMed ID: 28389892 [TBL] [Abstract][Full Text] [Related]
17. Defining Stage-Specific Activity of Potent New Inhibitors of Cryptosporidium parvum Growth Funkhouser-Jones LJ; Ravindran S; Sibley LD mBio; 2020 Mar; 11(2):. PubMed ID: 32127445 [No Abstract] [Full Text] [Related]
18. Cryptosporidiosis in India and the World: A Review. Sharma K; Srivastava S; Tak V Infect Disord Drug Targets; 2023; 23(5):e030423215404. PubMed ID: 37016532 [TBL] [Abstract][Full Text] [Related]
19. Distribution and clinical manifestations of Cryptosporidium species and subtypes in HIV/AIDS patients in Ethiopia. Adamu H; Petros B; Zhang G; Kassa H; Amer S; Ye J; Feng Y; Xiao L PLoS Negl Trop Dis; 2014 Apr; 8(4):e2831. PubMed ID: 24743521 [TBL] [Abstract][Full Text] [Related]
20. Genetic crosses within and between species of Shaw S; Cohn IS; Baptista RP; Xia G; Melillo B; Agyabeng-Dadzie F; Kissinger JC; Striepen B bioRxiv; 2023 Aug; ():. PubMed ID: 37577700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]